Figure 2 | Scientific Reports

Figure 2

From: Evaluating the cost-effectiveness of a pre-exposure prophylaxis program for HIV prevention for men who have sex with men in Japan

Figure 2

Yearly cost distribution over 30 years. Yearly costs related to treatment, screening, and pre-exposure prophylaxis (PrEP) were computed assuming an annual discount rate of 2%. (a) Yearly cost if PrEP is not introduced. (b) Yearly cost with the introduction of PrEP to 50% of the cohort. (c) Yearly cost with the introduction of PrEP to the whole cohort. (d) Difference in yearly cost between when PrEP is introduced with different coverages (50% or 100%) versus when PrEP is not introduced. (e) Cumulative cost if PrEP is not introduced. (f) Cumulative cost with the introduction of PrEP to 50% of the cohort. (g) Cumulative cost with the introduction of PrEP to the whole cohort. (h) Difference in cumulative cost between when PrEP is introduced with different coverages (50% or 100%) versus when PrEP is not introduced.

Back to article page